Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

274
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
274
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

526
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
526
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

462
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
462

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of severe maternal morbidity with epilepsy diagnosis in children: a population-based birth cohort study.

International journal of epidemiology·2026
Same author

AI and the cancer workforce: what problem are we solving?

The Lancet. Oncology·2026
Same author

Integrating artificial intelligence tools in health research.

NPJ digital medicine·2026
Same author

Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

European urology·2026
Same author

The Link Between Life Satisfaction and Outcome-wide Health: Evidence from the Canadian Longitudinal Study on Aging.

American journal of epidemiology·2026
Same author

A qualitative assessment of the use of artificial intelligence in public sector health organisations in Ontario, Canada.

Swiss medical weekly·2026

Related Experiment Video

Updated: Jan 6, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K

Predicting All-Cause Mortality in Diabetic Patients 2 Years in Advance Using Aggregated EHR Data and Machine

Neda Aminnejad1, Emmalin Buajitti2,3, Laura C Rosella2,3

  • 1Department of Mathematics and Statistics, York University, Toronto, ON, Canada. neda2727@yorku.ca.

Journal of Medical Systems
|October 14, 2025
PubMed
Summary

This study developed a machine learning model to predict all-cause mortality in diabetic patients two years in advance. The model uses common health data and achieves high accuracy, improving risk identification for better patient management.

Keywords:
Diabetes mellitusEHR dataMachine learningMortalityXGBoost

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Related Experiment Videos

Last Updated: Jan 6, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Area of Science:

  • Healthcare Informatics
  • Machine Learning in Medicine
  • Predictive Analytics

Background:

  • Diabetic patients face elevated all-cause mortality risks.
  • Existing mortality prediction models often lack generalizability or rely on limited variables.
  • Accurate, early prediction of mortality is crucial for proactive patient management in diabetes care.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting all-cause mortality in diabetic patients.
  • To leverage comprehensive administrative health data for enhanced predictive accuracy.
  • To identify key risk factors associated with mortality in this population.

Main Methods:

  • Utilized XGBoost algorithm on a dataset of 1553 variables from administrative health records.
  • Included hospitalization, emergency department visits, demographics, and chronic disease information.
  • Evaluated model performance using Area Under the Curve (AUC).

Main Results:

  • Achieved an AUC of 0.89, outperforming existing models.
  • Identified significant predictors: age, immigration status, comorbidity diagnosis age, number, and duration.
  • Demonstrated robust discrimination and calibration using commonly available primary care data.

Conclusions:

  • The machine learning model effectively predicts two-year all-cause mortality in diabetic patients.
  • The model's reliance on accessible data facilitates broad clinical application.
  • Findings support improved patient management and resource allocation through early risk stratification.